Government of Saskatchewan ministries, Crown corporations and organizations are working to minimize the impacts of the postal service disruption.
Les ministères, les sociétés d’État et les organismes du gouvernement de la Saskatchewan travaillent à réduire au minimum les répercussions de l’interruption des services postaux.
Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Released on May 1, 2025
Saskatchewan residents living with epilepsy will now have another medication available for their treatment. Beginning May 1, the Government of Saskatchewan is adding the anti-seizure medication Xcopri to the Saskatchewan Formulary to treat patients with epilepsy.
"Individuals living with epilepsy and the specialists who care for them have been calling for access to this medication. We're proud to respond to that call," Health Minister Jeremy Cockrill said. "This drug offers real hope to people struggling with uncontrolled seizures. It could mean fewer hospital visits, fewer surgeries, and a better quality of life."
Epilepsy is a chronic disease characterized by seizures. The cause of epilepsy can include infections, genetics, trauma, stroke and tumors.
Xcopri is an epilepsy medication that is used along with other medications to manage seizures that are not controlled with other therapies. Approximately 10,500 people in Saskatchewan live with epilepsy. It's estimated about 100 people could benefit from this medication in the first year of coverage.
"XCopri has shown it has the potential to reduce/control seizures, even for a demographic that has historically struggled with seizure control," Epilepsy Saskatoon President Lori Newman said. "By having the government add XCopri to the Saskatchewan Formulary, tangible hope exists for people living with epilepsy that their doctor now has unimpeded access to prescribe a new medication - one that has the power to be life-changing."
Drug funding decisions in Saskatchewan are informed through a rigorous review process that includes medication assessment through Canada's Drug Agency, the provincial Drug Advisory Committee of Saskatchewan, and manufacturer pricing negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA). Saskatchewan is a member of the pCPA and works collaboratively with other provinces and territories to achieve better value for the publicly funded drug plans as well as patients.
The Saskatchewan Formulary offers a variety of medications that may be appropriate for epilepsy patients. Patients are encouraged to discuss their medication needs with their health care provider.
Criteria for coverage of Xcopri is listed on the Saskatchewan Formulary.
-30-
For more information, contact:We need your feedback to improve saskatchewan.ca. Help us improve
